Dyne Therapeutics Inc (NASDAQ: DYN) started the day on Wednesday, with a price decrease of -3.32% at $18.9, before settling in for the price of $19.55 at the close. Taking a more long-term approach, DYN posted a 52-week range of $6.36-$26.69.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -59.45%. Meanwhile, its Annual Earning per share during the time was -59.45%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.60%. This publicly-traded company’s shares outstanding now amounts to $142.61 million, simultaneously with a float of $118.92 million. The organization now has a market capitalization sitting at $3.06 billion. At the time of writing, stock’s 50-day Moving Average stood at $19.38, while the 200-day Moving Average is $13.37.
Dyne Therapeutics Inc (DYN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Dyne Therapeutics Inc’s current insider ownership accounts for 26.51%, in contrast to 72.49% institutional ownership.
Dyne Therapeutics Inc (DYN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
Dyne Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -4.60% and is forecasted to reach -3.28 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.83% through the next 5 years, which can be compared against the -59.45% growth it accomplished over the previous five years trading on the market.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Let’s observe the current performance indicators for Dyne Therapeutics Inc (DYN). It’s Quick Ratio in the last reported quarter now stands at 13.47. In the same vein, DYN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.66, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -3.28 at the market close of one year from today.
Technical Analysis of Dyne Therapeutics Inc (DYN)
If we take a close look at the recent performances of Dyne Therapeutics Inc (NASDAQ: DYN), its last 5-days Average volume was 3.19 million that shows progress from its year to date volume of 2.71 million. During the previous 9 days, stock’s Stochastic %D was recorded 19.77% While, its Average True Range was 42.21.
Raw Stochastic average of Dyne Therapeutics Inc (DYN) in the period of the previous 100 days is set at 62.16%, which indicates a major rise in contrast to 12.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.44 that was higher than 1.04 volatility it exhibited in the past 100-days period.
